– Arc Medical Design Limited, a subsidiary of Norgine B.V., today announced that the High Court of Justice England and Wales, Patents Court ruled that ENDOCUFFR and ENDOCUFF VISIONR UK national and UK(EP) patents (as amended) are valid and infringed by Cantel’s AmplifEYER endoscopic device, and key design rights are valid and infringed by AmplifEYER. The patent and design rights had been challenged by Cantel Medical (UK) Limited and Cantel (UK) Limited.
(Logo: http://mma.prnewswire.com/media/597589/Norgine_Logo.jpg )
Peter Martin, COO of Norgine and Chair of the Arc Medical Design Limited Board said: “We welcome the judgement and our resounding success, recognising the strong protection for both ENDOCUFFR and ENDOCUFF VISIONR. This decision validates our confidence in the intellectual property portfolio protecting our products. We will always vigorously defend our intellectual property and will initiate legal proceedings where appropriate.”
ENDOCUFF VISIONR is a single use device attached at the end of the colonoscope that gives an optimal view of the entire colon by retracting folds during withdrawal.
Notes to Editors:
About the UK Case No. HP-2016-000047
On Friday 23 February 2018 the High Court of Justice England and Wales, Patents Court ruled that:Arc Medical Design Limited won on all counts:
View the full media release onhttp://www.norgine.com/media
Media Contact:
Isabelle Jouin, T: +44 (0)1895 453643
Follow us @norgine
(Immediapress – Adnkronos
Immediapress e’ un servizio di diffusione di comunicati stampa in testo originale redatto direttamente dall’ente che lo emette. Padovanews non e’ responsabile per i contenuti dei comunicati trasmessi.)